Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,017
Closed -$293K 742
2023
Q2
$293K Buy
1,017
+223
+28% +$67.7K 0.02% 598
2023
Q1
$234K Hold
794
0.01% 656
2022
Q4
$234K Buy
+794
New +$219K 0.01% 656
2022
Q3
Sell
-971
Closed -$212K 799
2022
Q2
$212K Buy
971
+197
+25% +$44.8K 0.01% 761
2022
Q1
$206K Buy
+774
New +$190K 0.01% 789
2021
Q2
Sell
-1,784
Closed -$465K 852
2021
Q1
$465K Buy
+1,784
New +$478K 0.02% 485
2018
Q2
Sell
-3,103
Closed -$269K 1041
2018
Q1
$269K Sell
3,103
-931
-23% -$72.3K 0.01% 1023
2017
Q4
$278K Sell
4,034
-1,666
-29% -$109K 0.01% 1075
2017
Q3
$314K Buy
5,700
+5
+0.1% +$273 0.01% 1024
2017
Q2
$292K Sell
5,695
-408
-7% -$17.7K 0.01% 995
2017
Q1
$263K Sell
6,103
-899
-13% -$38.6K 0.01% 1018
2016
Q4
$264K Buy
7,002
+66
+1% +$2.46K 0.01% 992
2016
Q3
$284K Buy
+6,936
New +$274K 0.01% 789

Other funds holding PODD

FDx Advisors's PODD Position: Q3 2023 in Review

FDx Advisors sold out of Insulet (PODD) in Q3 2023, closing a stake of 1,017 shares — an estimated $293K sold.

FDx Advisors first reported a position in PODD in Q3 2016 and held it in 13 quarters. The position peaked at $465K in Q1 2021. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • FDx Advisors reported no remaining Insulet position as of Q3 2023 after selling out during the quarter.
  • FDx Advisors sold 1,017 Insulet shares in Q3 2023, an estimated $293K.
  • FDx Advisors first reported a position in Insulet in Q3 2016 and held it in 13 quarters.
  • FDx Advisors's Insulet position peaked at $465K in Q1 2021.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.